04:04
Testing and treating: Hepatitis C in Queensland's correctional facilities
47:39
Joyce Huei-Jiuan Wu β The impact and cost-effectiveness of simplified HCV diagnosis
01:32:37
Hepatitis C elimination progress in NSW: successes and future challenges
57:06
Dr Robyn Stuart β Starsim: A new agent-based framework for modelling HIV and STI co-transmission
01:00:51
Dr James Bedford β AI in Academic Research and Writing: Potentials, pitfalls and possibilities
59:36
Prof Joshua T Schiffer β Accurate simulation of SARS-CoV-2 clinical trials and immune responses
57:45
Kate Burry β Cook Islands womenβs wellbeing and safety in the context of abortion
46:52
Kirby at CROI 2024
42:31
Anna Conway - Developing enabling environments to improve the health of people who use opioids
56:24
Prof Henry de Vries β The aftermath of the COVID-19 pandemic on sexual health & STI epidemiology
01:22:55
International Women's Day 2024 β Count Her In: Invest in women. Accelerate Progress.
00:45
CHART Program 2023 - Narukjaporn Thammajaruk - Thailand
01:06:20
Ziyad Al Aly - Long COVID: the lasting legacy of the COVID-19 pandemic
44:35
Dr Gabriel Duette β HIV persistence is promoted by the TB-Associated Microenvironment
04:09
βItβs about the conversationβ: Sexual Health Enhanced Walkabout
51:11
Reflections on the International Health Economics Association Conference
51:03
John Paul Caesar Delos Trinos β Cost-effectiveness of mass drug administration for intestinal worms
01:03:38
Braulio Mark Valencia Arroyo β Host & pathogen genetic determinants of severe acute viral infections
01:00:59
Together TakeMeHome: Implementing a Nationwide Mailed HIV Self-Testing Program
01:22:37
Public health interventions to address HIV disparities: Insights from USA
01:08:26
Special Seminar: Progress towards ending HIV/AIDS
01:00:07
A/Prof Thomas Tu β Hepatitis B virus persistence and pathways towards liver cancer
58:37
Progress towards hepatitis C elimination: Insights from modelling
08:30
Point-of-care hepatitis C virus RNA testing: A step by step guide
01:14:38
David Cooper Lecture | Michael Kirby: Health & Human Rights
56:51
Dr Anthony K J Smith - Making PrEP work: understanding drug adherence as a domestic practice
59:53
POC23 β The 1st Australasian Conference on point-of-care testing for infectious disease
59:50
Prof Deborah Williamson β Innovative approaches to the detection and control of infectious diseases
49:44
Dr Alexander Underwood - Unravelling the neutralising antibody response to SARS-CoV-2
57:14
Dr Sarah K. Calabrese - Stigma: An unintended consequence of targeted PrEP social marketing
01:29:39
International Women's Day 2023 β Dismantling barriers for a gender equal future
49:58
Professor Jake Baum β Paratechnology: New tools for malaria control and eradication
02:16:07
HIV seroconversion over time: 30 years exploring accounts of HIV infection and diagnosis
55:53
Neglected tropical diseases: modelling and simulation for public health policy
58:12
Reflection on PrEP implementation in Taiwan
59:14
Modelling the impact of public health interventions in the prison setting
54:30
Brett Tindall Memorial Lecture 2022: Associate Professor Behzad Hajarizadeh
42:55
Dr Samuel Brookfield β Developing a posthumanist model of 'Extended Recovery' for harmful drug use
42:24
Kirby Institute Postgraduate Student Prize 2022: Dr Nila Dharan
05:45
Hereβs your STI check, Australia
55:28
Professor Joel Palefsky & Dr Mary Poynten: Anal cancer prevention in people living with HIV
01:28:30
Monkeypox: what we know and what we need to learn
57:45
Dr Muhammad Shahid Jamil β HIV self-testing: global updates, innovations and what's next
03:38
We are the AMR Hub: A wholistic approach to combating antimicrobial resistance
01:55
What is AMR? Antimicrobial resistance explained
39:52
Launch of ARC Industrial Transformation Research Hub to Combat Antimicrobial Resistance (AMR Hub)
01:30:35
Strategies to find, test, and treat people living with hepatitis C in Australia
57:15
Transgender health, community and experience in Indonesia: Teddy Cook and Dr Alegra Wolter
01:01:35
Professor Dominic Dwyer β More virus drama: the emergence of Japanese encephalitis in Australia
55:25
Professor Sinead Delany-Moretlwe β Roll-out of new HIV prevention technologies
58:39
Limin Mao & Horas Wong: HIV & STI behavioural surveillance among Australian Asian gay & bisexual men
42:19
Ms Louise Geddes β An investigation of health-related harms associated with opioid injection
50:59
Ms Mohana Priya Kunasekaran β Impact of influenza in aged care facilities in Sydney, Australia
05:20
Single-visit hepatitis C testing and treatment among people who inject drugs: The TEMPO Pilot Study
01:28:53
Emeritus Prof Robin Wood & Prof Linda-Gail Bekker β TB and COVID-19: Insights from South Africa
53:47
Dr Huachun Zou β HIV pre-exposure prophylaxis (PrEP) in China: challenges and opportunities
01:00:00
Mr Curtis Chan β Knowledge and Use of Event-Driven PrEP in Australia
41:18
Longitudinal characterisation of anti-Spike antibodies mediated functions in COVID-19 patients
01:28:08
International Women's Day 2022 β Diversity in womenβs sexual health and wellbeing
02:39
Professor Rebecca Guy receives the 2022 Gustav Nossal Medal for Global Health
X
About
The Kirby Institute is a leading global research institute dedicated to the prevention and treatment of infectious diseases. We were established in 1986 in response to the then emerging HIV epidemic. We now contribute to knowledge on a broad range of diseases, including viral hepatitis and sexually transmissible infections.
Our primary work relates to the coordination of national surveillance programs, population health and epidemiological research, clinical and behavioural research and clinical trials. Our research projects are conducted in partnership with communities most affected by epidemics. Together we implement trials of behavioural and biomedical interventions designed to prevent the spread of infectious diseases in vulnerable populations.
Tags